Literature DB >> 33741590

Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis.

Axel Patrice Villani1,2, Aurore Rozieres1, Benoît Bensaid2, Klara Kristin Eriksson3, Amandine Mosnier1, Floriane Albert1, Virginie Mutez1, Océane Brassard1, Tugba Baysal1, Mathilde Tardieu1, Omran Allatif1, Floriane Fusil1, Thibault Andrieu1,4, Denis Jullien1,2, Valérie Dubois5, Catherine Giannoli5, Henri Gruffat1, Marc Pallardy6, François-Loïc Cosset1, Audrey Nosbaum1,7, Osami Kanagawa1, Janet L Maryanski8, Daniel Yerly3,9, Jean-François Nicolas1,7, Marc Vocanson10.   

Abstract

Toxic epidermal necrolysis (TEN) is a life-threatening cutaneous adverse drug reaction. To better understand why skin symptoms are so severe, we conducted a prospective immunophenotyping study on skin and blood. Mass cytometry results confirmed that effector memory polycytotoxic CD8+ T cells (CTLs) are the main leucocytes in TEN blisters at the acute phase. Deep T cell receptor (TCR) repertoire sequencing identified massive expansion of unique CDR3 clonotypes in blister cells. The same clones were highly expanded in patient's blood, and the degree of their expansion showed significant correlation with disease severity. By transducing α and β chains of the expanded clonotypes into a TCR-defective cell line, we confirmed that those cells were drug specific. Collectively, these results suggest that the relative clonal expansion and phenotype of skin-recruited CTLs condition the clinical presentation of cutaneous adverse drug reactions.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33741590      PMCID: PMC7978430          DOI: 10.1126/sciadv.abe0013

Source DB:  PubMed          Journal:  Sci Adv        ISSN: 2375-2548            Impact factor:   14.136


  51 in total

1.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.

Authors:  Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

2.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Jui-Yung Yang; Shih-Chi Su; Shien-Ping Huang; Chun-Yu Wei; See-Wen Chin; Chien-Chun Chiou; Sung-Chao Chu; Hsin-Chun Ho; Chih-Hsun Yang; Chi-Fang Lu; Jer-Yuarn Wu; You-Di Liao; Yuan-Tsong Chen
Journal:  Nat Med       Date:  2008-11-23       Impact factor: 53.440

3.  NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions.

Authors:  C Schlapbach; A Zawodniak; N Irla; J Adam; R E Hunger; D Yerly; W J Pichler; N Yawalkar
Journal:  Allergy       Date:  2011-08-05       Impact factor: 13.146

4.  Pathogenesis of drug-induced exanthema.

Authors:  N Yawalkar; W J Pichler
Journal:  Int Arch Allergy Immunol       Date:  2001 Jan-Mar       Impact factor: 2.749

5.  Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.

Authors:  Tai-Ming Ko; Wen-Hung Chung; Chun-Yu Wei; Han-Yu Shih; Jung-Kuei Chen; Chia-Hsien Lin; Yuan-Tsong Chen; Shuen-Iu Hung
Journal:  J Allergy Clin Immunol       Date:  2011-09-14       Impact factor: 10.793

6.  T cell involvement in cutaneous drug eruptions.

Authors:  Y Hari; K Frutig-Schnyder; M Hurni; N Yawalkar; M P Zanni; B Schnyder; A Kappeler; S von Greyerz; L R Braathen; W J Pichler
Journal:  Clin Exp Allergy       Date:  2001-09       Impact factor: 5.018

7.  ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis.

Authors:  B Sassolas; C Haddad; M Mockenhaupt; A Dunant; Y Liss; K Bork; U F Haustein; D Vieluf; J C Roujeau; H Le Louet
Journal:  Clin Pharmacol Ther       Date:  2010-04-07       Impact factor: 6.875

8.  Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies.

Authors:  P C Kuechler; M Britschgi; S Schmid; Y Hari; B Grabscheid; W J Pichler
Journal:  Allergy       Date:  2004-06       Impact factor: 13.146

9.  Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.

Authors:  Jacqueline Adam; Natascha Wuillemin; Stephan Watkins; Heidi Jamin; Klara K Eriksson; Peter Villiger; Stefano Fontana; Werner J Pichler; Daniel Yerly
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 10.  Epidemiology of cutaneous adverse drug reactions.

Authors:  M Mockenhaupt
Journal:  Allergol Select       Date:  2017-08-04
View more
  5 in total

1.  In Vitro Monitoring of Human T Cell Responses to Skin Sensitizing Chemicals-A Systematic Review.

Authors:  Marina Aparicio-Soto; Caterina Curato; Franziska Riedel; Hermann-Josef Thierse; Andreas Luch; Katherina Siewert
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

2.  Frequencies and TCR Repertoires of Human 2,4,6-Trinitrobenzenesulfonic Acid-specific T Cells.

Authors:  Caterina Curato; Marina Aparicio-Soto; Franziska Riedel; Ingrun Wehl; Alev Basaran; Amro Abbas; Hermann-Josef Thierse; Andreas Luch; Katherina Siewert
Journal:  Front Toxicol       Date:  2022-02-22

3.  Risk Assessment in Drug Hypersensitivity: Detecting Small Molecules Which Outsmart the Immune System.

Authors:  Werner J Pichler; Stephen Watkins; Daniel Yerly
Journal:  Front Allergy       Date:  2022-02-22

4.  IL-15/IL-15Rα in SJS/TEN: Relevant Expression of IL15 and IL15RA in Affected Skin.

Authors:  Teresa Bellón; Olga González-Valle; Elena Sendagorta; Victoria Lerma; Javier Martínez Del Río; Celia Martínez; Guillermo Servera; Carlos González-Herrada; Lucía Cachafeiro; José A Lorente; Rosario Cabañas; Pedro Herranz; Francisco de Abajo
Journal:  Biomedicines       Date:  2022-08-02

Review 5.  Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.

Authors:  Pooja Deshpande; Rebecca J Hertzman; Amy M Palubinsky; Jason B Giles; Jason H Karnes; Andrew Gibson; Elizabeth J Phillips
Journal:  Clin Pharmacol Ther       Date:  2021-07-17       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.